Urothelial Carcinoma

Scoring Systems for Immunohistochemistry in Urothelial Carcinoma.- A Panel-Based Method for the Reproduction of Distinct Molecular Subtype Classifications of Muscle-Invasive Urothelial Bladder Cancer.- Analysis of Mutational Signatures Using the mutSignatures R Library.- A Drug Repurposing Pipeline Based on Bladder Cancer Integrated Proteotranscriptomics Signatures.- Characterization of Native COMPASS Complex in Urothelial Carcinoma Cells by Size Exclusion Chromatography.- Reconstructing Phylogenetic Relationship in Bladder Cancer: A Methodological Overview.- Using Sister Chromatid Exchange Assay to Detect Homologous Recombination Deficiency in Epigenetically Deregulated Urothelial Carcinoma Cells.- Identification of STAG2 Mutant Bladder Cancers by Immunohistochemistry.- Genome-Wide CRISPR Screening for the Identification of Therapy-Resistance-Associated Genes in Urothelial Carcinoma.- Tissue Slice Culture and Analysis of Tumor-Associated Hyaluronan in Urothelial Carcinoma.- NGS-Based Tumor-Informed Analysis of Circulating Tumor DNA.- Considering the Effects of Modern Point-of-Care Urine Biomarker Assays in Follow-Up of Patients with High-Risk Non-Muscle Invasive Bladder Cancer.- Simplex Droplet Digital PCR Assays for the Detection of TERT Promoter Mutations in Urine Samples for the Non-Invasive Diagnosis of Urothelial Cancer.- Predictive Biomarkers of Response to Neoadjuvant Therapy in Muscle Invasive Bladder Cancer.- Assessment of PD-L1 Status in Urothelial Cancer.- Epigenetic Priming and Development of New Combination Therapy Approaches.- Evaluation of FGFR Alteration Status in Urothelial Tumors.- Antibody-Drug-Conjugates (ADC): A Novel Treatment Option in Urothelial Carcinoma.- Intravesical Infusion of Oncolytic Virus CG0070 in the Treatment of Bladder Cancer.- Analysis of ICAM-1 Expression on Bladder Carcinoma Cell Lines and Infectivity and Oncolysisby Coxsackie Virus A21.